- Half Year 2023 Mithra Pharmaceuticals SA Earnings Call TranscriptSep 26, 2023€2.06 (-0.72%)Earnings
- Q4 2022 Mithra Pharmaceuticals SA Earnings Call TranscriptMar 07, 2023€3.12 (+14.52%)Earnings
- Mithra Pharmaceuticals SA and Richter Gedeon Vegyeszeti Gyar Nyrt to Discuss Partnership for the Commercialisation of Donesta Presentation TranscriptDec 20, 2022
- Q2 2022 Mithra Pharmaceuticals SA Earnings Call TranscriptSep 23, 2022€6.7 (+3.88%)Earnings
- Full Year 2021 Mithra Pharmaceuticals SA Earnings Call TranscriptMar 08, 2022€13.9 (-13.02%)Earnings
- Mithra Pharmaceuticals SA to Discuss Donesta Top-Line Results Call TranscriptJan 14, 2022
- Half Year 2021 Mithra Pharmaceuticals SA Earnings Call TranscriptSep 24, 2021€18.02 (-2.07%)Earnings
- Full Year 2020 Mithra Pharmaceuticals SA Earnings Call TranscriptMar 09, 2021€23.2 (+4.98%)Earnings
- Half Year 2020 Mithra Pharmaceuticals SA Earnings Call TranscriptSep 24, 2020€16.68 (-4.14%)Earnings
- Mithra Pharmaceuticals SA at Jefferies Healthcare Conference (Virtual) TranscriptJun 03, 2020
Full Year 2021 Mithra Pharmaceuticals SA Earnings Call Transcript
Hello, and welcome to the Mithra Full Year Results 2021 Conference Call. My name is Jeff, and I'll be your coordinator for today's event. (Operator Instructions)
I will now hand over to your host, Mr. Benoit Mathieu, Head of Investor Relations, to begin today's call. Thank you.
Good morning, ladies and gentlemen. Welcome to Mithra's Full Year Results 2021. My name is Benoit Mathieu, Group Investor Relations Manager. Thank you all for dialing into this conference call and for being with us for the presentation. I am joined in the room by our CEO, Mr. Leon Van Rompay; Mr. Christophe Marechal, CFO; Mr. Graham Dixon, Chief Scientific Officer; and Mr. Jean-Manuel Fontaine, Chief Business Officer.
This webcast is recorded, and the replay will be accessible later today on Mithra's website.
I would like to remind you that this webcast is covered by the disclaimer on Slide 2 of the presentation. The format of today's call will be as follows. A brief introduction will be given by
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)